Health Care · Services-Nursing & Personal Care Facilities · NYSE · CIK 1043000 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $40.75Day −5.39%Mkt cap $1.9B1Y +64.0%Off 52W high −8.2%Vol (1Y) 35.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,164 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest5.8% of sh out |
| Days to cover5.2d |
| 13F net flow (QoQ)+15.45% |
| Top-10 13F concentration79.5% |
| Next report (est.)2026-08-11 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$411.9M |
| Earnings (TTM)-$99.5M |
| Net margin−18.6% |
| Sales growth 3Y16.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+25.0% |
| 1Y+64.0% |
| 3Y+313.7% |
| Since incept. (ann.)+7.8% |
Total return through 2026-07-29 · series begins 2021-12-01. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)35.8% |
| Ann. volatility (3Y)58.9% |
| Sharpe (1Y)1.59 |
| Sharpe (3Y)1.10 |
| Max drawdown (1Y)−16.4% |
| Max drawdown (3Y)−41.0% |
| Beta (3Y vs SPY)1.07 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Conversant Capital LLC | 14.6M | $471M | 30.85% | +57.7% |
| Capital International Investors | 1.7M | $56M | 3.68% | new |
| Irenic Capital Management LP | 1.2M | $39M | 2.58% | +1049.3% |
| Hazelview Securities Inc. | 668,647 | $22M | 1.41% | −13.9% |
| J. Goldman & Co LP | 550,676 | $18M | 1.16% | +230.7% |
| Solas Capital Management, LLC | 445,879 | $14M | 0.94% | −2.1% |
| BlackRock, Inc. | 424,510 | $14M | 0.90% | −4.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | 363,741 | $12M | 0.77% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-11 | −$2.39 | — | $122.6M | +33.4% |
| 2025-12-31 | 2026-03-11 | — | — | $97.7M | +6.2% |
| 2025-09-30 | 2025-11-10 | −$1.56 | — | $98.0M | +31.2% |
| 2025-06-30 | 2025-08-11 | −$0.16 | — | $93.5M | +33.2% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-11 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
Reportable 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
